![PDF] A Comparative Study to Evaluate the Efficacy and Safety of Vildagliptin as an Add-on Therapy to a Low-Dose Metformin vs an Uptitration of Metformin in Type 2 DM Patients | Semantic PDF] A Comparative Study to Evaluate the Efficacy and Safety of Vildagliptin as an Add-on Therapy to a Low-Dose Metformin vs an Uptitration of Metformin in Type 2 DM Patients | Semantic](https://d3i71xaburhd42.cloudfront.net/a5c4ceb74433a774527304696b1430f52698bfb9/2-Table1-1.png)
PDF] A Comparative Study to Evaluate the Efficacy and Safety of Vildagliptin as an Add-on Therapy to a Low-Dose Metformin vs an Uptitration of Metformin in Type 2 DM Patients | Semantic
![PDF] Comparison of the Efficacy and Safety of Glimepiride/Metformin Fixed Combination Versus Free Combination in Patients with Type 2 Diabetes: Multicenter, Randomized, Controlled Trial | Semantic Scholar PDF] Comparison of the Efficacy and Safety of Glimepiride/Metformin Fixed Combination Versus Free Combination in Patients with Type 2 Diabetes: Multicenter, Randomized, Controlled Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/24e2aed0f9169ed1120b28d4c5b9c44c27d2b96d/3-Table1-1.png)
PDF] Comparison of the Efficacy and Safety of Glimepiride/Metformin Fixed Combination Versus Free Combination in Patients with Type 2 Diabetes: Multicenter, Randomized, Controlled Trial | Semantic Scholar
![Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects | Signal Transduction and Targeted Therapy Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01040-9/MediaObjects/41392_2022_1040_Fig1_HTML.png)